$4.97
▼ $-0.08
(-1.58%)
Vol 14K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$80.8M
ROE
-25.5%
Margin
-744.3%
D/E
0.00
Beta
0.88
52W
$6–$18
Wall Street Consensus
7 analysts · Apr 20263
Strong Buy
2
Buy
1
Hold
0
Sell
1
Strong Sell
71.4%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 75.0%
Next Report
May 06, 2026
EPS Estimate: $-0.71
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.71 | — | — |
| Dec 2025 | $-1.46 | $-1.42 | +$0.04 |
| Sep 2025 | $-1.29 | $-2.91 | $-1.62 |
| Jun 2025 | $-1.70 | $-0.72 | +$0.98 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-1… |
|---|---|---|---|---|
| Revenue | $3.5M | — | — | — |
| Net Income | -$3.2M | -$4.8M | -$24.8M | -$6.9M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -35.3% | -35.3% | -35.3% | -35.3% | -25.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -744.3% | -744.3% | -744.3% | -744.3% | -744.3% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 13.52 | 13.52 | 13.52 | 13.52 | 13.52 | 13.24 |
Key Ratios
ROA (TTM)
-22.4%
P/S (TTM)
8.82
EPS (TTM)
$-5.17
52W High
$18.00
52W Low
$5.75
$5.75
52-Week Range
$18.00
Financial Health
Free Cash Flow
-$7.2M
Net Debt
-$91.6M
Cash
$94.5M
Total Debt
$3.0M
As of Dec 31, 2025
How does IMA compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
IMA valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
8.8
▲
78%
above
peers
(5.0)
vs Peers
vs Industry
Pricier
P/B ratio
—
▼
0%
below
peers
(2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
IMA profitability vs Pharmaceuticals peers
ROE
-25.5%
▲
53%
above
peers
(-54.3%)
vs Peers
vs Industry
Below avg
Net margin
-744.3%
▼
1471%
below
peers
(-47.4%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-22.4%
▲
40%
above
peers
(-37.4%)
vs Peers
vs Industry
Below avg
IMA financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
13.2
▲
294%
above
peers
(3.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.9
▼
7%
below
peers
(0.9)
vs Peers
vs Industry
Less volatile
IMA fundamentals radar
IMA
Peer median
Industry
IMA profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
IMA vs peers: key metrics
Latest News
US Arrests & Boots Soleimani's Fashion Designer Niece From The Country
ZeroHedge · Apr 04
UK food halls buck downbeat hospitality trend: ‘In this impossible climate, they …
The Guardian · Apr 04
March Jobs Shocker: Payrolls Soar By 178K Most Since 2024, Blowing Away …
ZeroHedge · Apr 03
Stock Market Today, April 2: Tesla Falls After Vehicle Deliveries Miss Estimates
Nasdaq · Apr 03
Skanska Divests Ownership Of I-4 Ultimate
Nasdaq · Apr 02